14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.30 $2.08 Thursday, 2nd May 2024 CUE stock ended at $1.88. This is 1.31% less than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 9.99% from a day low at $1.76 to a day high of $1.94.
90 days $1.30 $2.58
52 weeks $1.30 $5.12

Historical Cue Biopharma Inc. prices

Date Open High Low Close Volume
May 02, 2024 $1.91 $1.94 $1.76 $1.88 223 037
May 01, 2024 $1.92 $1.97 $1.60 $1.91 622 035
Apr 30, 2024 $1.40 $1.98 $1.37 $1.90 1 239 085
Apr 29, 2024 $1.39 $1.48 $1.38 $1.42 154 331
Apr 26, 2024 $1.40 $1.44 $1.32 $1.37 261 676
Apr 25, 2024 $1.42 $1.42 $1.30 $1.41 161 672
Apr 24, 2024 $1.53 $1.54 $1.38 $1.42 316 786
Apr 23, 2024 $1.56 $1.60 $1.49 $1.50 160 821
Apr 22, 2024 $1.55 $1.58 $1.49 $1.57 181 253
Apr 19, 2024 $1.56 $1.61 $1.52 $1.56 167 072
Apr 18, 2024 $1.64 $1.65 $1.56 $1.58 169 208
Apr 17, 2024 $1.50 $1.64 $1.50 $1.63 313 072
Apr 16, 2024 $1.57 $1.67 $1.47 $1.50 286 535
Apr 15, 2024 $1.77 $1.77 $1.57 $1.60 238 979
Apr 12, 2024 $1.76 $1.76 $1.65 $1.75 342 870
Apr 11, 2024 $1.81 $1.85 $1.66 $1.76 423 009
Apr 10, 2024 $1.87 $1.90 $1.72 $1.78 244 353
Apr 09, 2024 $1.94 $1.96 $1.81 $1.90 537 903
Apr 08, 2024 $1.90 $2.08 $1.85 $2.04 436 879
Apr 05, 2024 $1.80 $1.85 $1.75 $1.85 219 411
Apr 04, 2024 $1.83 $1.87 $1.74 $1.78 226 142
Apr 03, 2024 $1.80 $1.84 $1.74 $1.77 273 822
Apr 02, 2024 $1.88 $1.95 $1.78 $1.82 233 393
Apr 01, 2024 $1.93 $1.94 $1.82 $1.90 181 615
Mar 28, 2024 $1.86 $1.94 $1.85 $1.89 187 949
Click to get the best stock tips daily for free!

About Cue Biopharma Inc.

Cue Biopharma. Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target and activate antigen-specific T cells for human papilloma virus-driven cancers. The company offers CUE-10... CUE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT